4.8 Article

Solvothermal Synthesis of ZnO Nanoparticles and Anti-Infection Application in Vivo

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 7, Issue 2, Pages 1308-1317

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/am507532p

Keywords

ZnO nanoparticles; elytritis model; antibacterial activities; minimum inhibition concentrations

Funding

  1. National Natural Science Foundation of China [81201814, 31270022, 81471784, 31271075, 51202260, 61171049]
  2. National Hi-Tech Research and Development Program of China [2013AA032201, 2012AA022701, 2011AA02A114]
  3. Beijing Nova Program [Z111103054511113]

Ask authors/readers for more resources

Zinc oxide nanoparticles (ZnONPs) have been widely studied as the bacteriostatic reagents. However, synthesis of small ZnO nanoparticles with good monodispersion and stability in aqueous solution is still a challenge. Anti-infection research of ZnONPs used as antibacterial agent in vivo is rare. In this paper, a novel, sustainable, and simple method to synthesize ZnO nanoparticles with good monodispersion in aqueous low-temperature conditions and with a small molecule agent is reported. Inhibition zone test and the minimum inhibitory concentration test were performed to examine the antibacterial activity of ZnONPs against bacteria Staphylococcus aureus and Escherichia coli in vitro. For further application in vivo, low cytotoxicity and low acute toxicity in mice of ZnO were demonstrated. Finally, 4 nm ZnONPs combined with poly(vinyl alcohol) gel was used as antibacterial agent in rodent elytritis model, and significant anti-infection effect was proven. In one word, the present research would shed new light on the designing of antibacterial materials like ZnO with promising application in disinfection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available